Biblio

Export 3292 results:
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
M. S. Weinberg, He, Y., Kivisäkk, P., Arnold, S. E., and Das, S., “Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S355-S365, 2024.
C. Weimar, Winkler, A., Dlugaj, M., Lehmann, N., Hennig, F., Bauer, M., Kröger, K., Kälsch, H., Mahabadi, A. - A., Dragano, N., Moebus, S., Hoffmann, B., Jöckel, K. - H., and Erbel, R., “Ankle-Brachial Index but Neither Intima Media Thickness Nor Coronary Artery Calcification is Associated With Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 2, pp. 433-42, 2015.
B. Weidung, Josefsson, M., Lyttkens, P., Olsson, J., Elgh, F., Lind, L., Kilander, L., and Lövheim, H., “Longitudinal Effects of Herpesviruses on Multiple Cognitive Outcomes in Healthy Elderly Adults.”, J Alzheimers Dis, vol. 94, no. 2, pp. 751-762, 2023.
I. W. Weidling, Wilkins, H. M., Koppel, S. J., Hutfles, L., Wang, X., Kalani, A., Menta, B. W., Ryan, B., Perez-Ortiz, J., T Gamblin, C., and Swerdlow, R. H., “Mitochondrial DNA Manipulations Affect Tau Oligomerization.”, J Alzheimers Dis, vol. 77, no. 1, pp. 149-163, 2020.
W. Wei, Liu, Y., Dai, C., Baazaoui, N., Tung, Y. - C., Liu, F., and Iqbal, K., “Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.”, J Alzheimers Dis, vol. 82, no. 2, pp. 631-646, 2021.
M. Wei, Zhao, B., Huo, K., Deng, Y., Shang, S., Liu, J., Li, Y., Ma, L., Jiang, Y., Dang, L., Chen, C., Wei, S., Zhang, J., Yang, H., Gao, F., and Qu, Q., “Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults.”, J Alzheimers Dis, vol. 57, no. 3, pp. 899-906, 2017.
E. X. Wei, Oh, E. S., Harun, A., Ehrenburg, M., and Agrawal, Y., “Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 995-1003, 2018.
E. M. Weekman and Wilcock, D. M., “Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia.”, J Alzheimers Dis, vol. 49, no. 4, pp. 893-903, 2016.
E. Wawrziczny, Berna, G., Ducharme, F., Kergoat, M. - J., Pasquier, F., and Antoine, P., “Modeling the Distress of Spousal Caregivers of People with Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 703-716, 2017.
A. Watts, Chalise, P., Hu, J., Hui, D., Pa, J., Andrews, S. J., Michaelis, E. K., and Swerdlow, R. H., “A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.”, J Alzheimers Dis, vol. 89, no. 3, pp. 913-922, 2022.
A. D. Watt, Jenkins, N. L., McColl, G., Collins, S., and Desmond, P. M., “Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1311-1316, 2019.
W. Watremez, Jackson, J., Almari, B., McLean, S. L., Grayson, B., Neill, J. C., Fischer, N., Allouche, A., Koziel, V., Pillot, T., and Harte, M. K., “Stabilized Low-n Amyloid-β Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.”, J Alzheimers Dis, vol. 62, no. 1, pp. 213-226, 2018.
A. Watad, Bragazzi, N. L., Tiosano, S., Yavne, Y., Comaneshter, D., Cohen, A. D., and Amital, H., “Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 117-124, 2018.
M. Waragai, Ho, G., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Masliah, E., and Hashimoto, M., “Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1249-1253, 2020.
M. Waragai, Adame, A., Trinh, I., Sekiyama, K., Takamatsu, Y., Une, K., Masliah, E., and Hashimoto, M., “Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1453-9, 2016.
M. Waragai, Moriya, M., and Nojo, T., “Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1411-1427, 2017.
J. Wang, Yuan, Y., Cai, R., Huang, R., Tian, S., Lin, H., Guo, D., and Wang, S., “Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 63, no. 2, pp. 835-845, 2018.
J. Wang, Zhang, G., Lai, H., Li, Z., Shen, M., Li, C., Kwan, P., O'Brien, T. J., Wu, T., Yang, S., Zhang, X., and Zhang, L., “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
Q. Wang, Guo, L., Thompson, P. M., Jack, C. R., Dodge, H., Zhan, L., and Zhou, J., “The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1.”, J Alzheimers Dis, vol. 64, no. 1, pp. 149-169, 2018.
L. Wang, Chen, H., Tang, J., Guo, Z., and Wang, Y., “Peptidylarginine Deiminase and Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.
X. Wang, Huang, R., Huang, B., and Li, X., “S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1489-1504, 2023.
J. Wang, Tan, L., and Yu, J. - T., “Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.”, J Alzheimers Dis, vol. 50, no. 4, pp. 927-45, 2016.
X. Wang, Li, F., Gao, Q., Jiang, Z., Abudusaimaiti, X., Yao, J., and Zhu, H., “Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis.”, J Alzheimers Dis, vol. 87, no. 1, pp. 285-304, 2022.
E. Wang, Zhu, H., Wang, X., Gower, A., Wallack, M., Blusztajn, J. Krzysztof, Kowall, N., and Qiu, W. Qiao, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
X. Wang, Bui, H., Vemuri, P., Graff-Radford, J., Jack, C. R., Petersen, R. C., and Mielke, M. M., “Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 81, no. 2, pp. 533-543, 2021.

Pages